Clinical Trial Update: PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study [Phase 2]

View source ↗

Summary

The Phase 2 PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study for prostate cancer was terminated, and results were posted on 2025-02-28.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-02-28